Skip to main content

Table 1 Patient demographics

From: PD-L1 and CD4 are independent prognostic factors for overall survival in endometrial carcinomas

Characteristic

Number (n = 221)

%

Median age (range)

57 (26–84)

FIGO stage

 I

144

 

65

  IA

 

110

50

  IB

 

34

15

 II

17

 

8

 III

36

 

16

  IIIA

 

13

6

  IIIC

 

23

10

 IV

24

 

11

  IVA

 

2

1

  IVB

 

22

10

Histotype

 Endometrioid

196

 

89

  G1

 

115

52

  G2

 

56

25

  G3

 

25

11

 Serous

12

 

5

 Adenosquamous

4

 

2

 Clear cell

4

 

2

 Poorly differentiated

1

 

0

 Undifferentiated

1

 

0

 Mixed epithelial

3

 

1

Myometrial invasion> 1/2

81

 

37

Lymphovascular space invasion

84

 

38

Primary treatment

   

 Surgery

221

 

100

  Lymphadenectomy

 

171

77

  Lymphnode sampling

 

21

10

  Lymphnode not removed

 

29

13

 Adjuvant chemotherapy

60

 

27

  TC

 

55

25

  CAP

 

4

2

 Adjuvant radiotherapy

58

 

26

  1. Abbreviations: FIGO International Federation of Gynecology and Obstetrics, TC paclitaxel and carboplatin combination, CAP cyclophosphamide, doxorubicin, and cisplatin combination
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us